IP Verse

Bayer Pharma Ag V. Apotex Inc. - 1:22-cv-01596

Explore the details of the Bayer Pharma Ag V. Apotex Inc. case under case number 1:22-cv-01596 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:22-cv-01596
Filing Date
Dec 14, 2022
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Bayer Pharma AG -
Apotex Inc. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jan 27, 2023WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Apotex Corp. waiver sent on 1/3/2023, answer due 3/6/2023. (Fahnestock, Derek) (Entered: 01/27/2023)PACER Document
Mar 7, 2023MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023)PACER Document
Mar 7, 2023Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023)PACER Document
Mar 7, 2023Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceuticals Holdings, Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023)PACER Document
Mar 7, 2023ANSWER to 1 Complaint and COUNTERCLAIMS against all Plaintiffs, by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) Modified on 3/8/2023 (nms). (Entered: 03/07/2023)PACER Document
Mar 8, 2023NOTICE OF SERVICE of (1) Apotex's ANDA Production and (2) Apotex's Core Technical Documents Production filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 03/08/2023)PACER Document
Mar 24, 2023ANSWER to 11 Answer to Complaint, and Counterclaims, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 3/24/2023 (nms). (Entered: 03/24/2023)PACER Document
Jun 2, 2023STIPULATION and Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). (Entered: 06/02/2023)PACER Document
Jun 2, 2023STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). (Entered: 06/02/2023)PACER Document
Jun 20, 2023SO ORDERED Granting (D.I. 155 in 21-md-3017-RGA; D.I. 146 in 21-cv-314-RGA-JLH; D.I. 18 in 22-cv-1596-RGA) Stipulation and Order Regarding Consolidation and Scheduled. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:22-cv-01596-RGA(nms) (Entered: 06/20/2023)PACER Document
Jun 20, 2023SO ORDERED Granting (D.I. 154 in 21-md-3017-RGA; D.I. 17 in 22-cv-1596-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms) (Entered: 06/20/2023)PACER Document
May 30, 2025NOTICE of Withdrawal of Counsel by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals Inc. (Smith, Rodger) (Entered: 05/30/2025)PACER Document
Dec 21, 2022Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)PACER Document
Mar 7, 2023CORRECTING ENTRY: The Answer (D.I. 11), 7.1 Disclosure Statements (D.I. 12; D.I. 13), and Motion for Pro Hac (D.I. 14) filed on 3/6/2023, have all been removed from the docket. Upon review it was determined this case is a member to MDL 21-3017-RGA. All filings need to bear a dual caption to the MDL case as well as the underlying civil action and be filed accordingly. Defendants are requested to amend and resubmit the filings. (nms)PACER Document
Mar 7, 2023SO ORDERED, re (D.I. 14 in 22-cv-1596-RGA; D.I. 145 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 3/7/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms)PACER Document
Mar 7, 2023Pro Hac Vice Attorney Brian Sodikoff and Rachel L. Schweers for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)PACER Document